Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
VO2 max
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
===Calculation: the Fick equation=== {{Main|Fick principle}} VΜO<sub>2</sub> may also be calculated by the [[Fick principle|Fick equation]]: <math chem>\ce{\dot VO2} = Q \times\ (C_a\ce{O2} - C_v\ce{O2})</math>, when these values are obtained during exertion at a maximal effort. Here ''Q'' is the [[cardiac output]] of the heart, ''C<sub>a</sub>''O<sub>2</sub> is the arterial oxygen content, and ''C<sub>v</sub>''O<sub>2</sub> is the venous oxygen content. (''C<sub>a</sub>''O<sub>2</sub> β ''C<sub>v</sub>''O<sub>2</sub>) is also known as the [[arteriovenous oxygen difference]]. The Fick equation may be used to measure VΜO<sub>2</sub> in critically ill patients, but its usefulness is low even in non-exerted cases.<ref>{{cite journal |last1=Thrush |first1=DN |title=Spirometric versus Fick-derived oxygen consumption: which method is better? |journal=Critical Care Medicine |date=January 1996 |volume=24 |issue=1 |pages=91β5 |doi=10.1097/00003246-199601000-00016 |pmid=8565545}}</ref> Using a breath-based VO<sub>2</sub> to estimate cardiac output, on the other hand, seems to be reliable enough.<ref>{{cite journal |last1=Fanari |first1=Z |last2=Grove |first2=M |last3=Rajamanickam |first3=A |last4=Hammami |first4=S |last5=Walls |first5=C |last6=Kolm |first6=P |last7=Saltzberg |first7=M |last8=Weintraub |first8=WS |last9=Doorey |first9=AJ |title=Cardiac output determination using a widely available direct continuous oxygen consumption measuring device: a practical way to get back to the gold standard. |journal=Cardiovascular Revascularization Medicine: Including Molecular Interventions |date=June 2016 |volume=17 |issue=4 |pages=256β61 |doi=10.1016/j.carrev.2016.02.013 |pmid=26976237 |pmc=4912455}}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)